OncoArendi Therapeutics

Poland
Wysokie Mazowieckie, Podlasie, Poland, 02-089

Company profile

OncoArendi Therapeutics company profile

OncoArendi Therapeutics is a biopharmaceutical company devoted to finding, creating, and marketing treatments for inflammatory and cancerous conditions. The Company's business strategy is solely centered on the discovery and development of new drugs, and it leverages its strengths in medicinal chemistry and preclinical biology as well as research partnerships with public intellectuals in particular disease areas.

Business identity

Contact email
[email protected]
Phone number
+48 728 728 143
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2012-01-01, Year

Headquarters

Postal code
02-089
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$8.8M
Last funding
Series A / $4.4M / 2017-03-08
Last equity funding
Series A / $4.4M
Investors
4
Lead investors
2
Founders
2
Articles
3
Exited on
2018-04-19

Founders and investors

Founders

Jacek OlczakStanislaw Pikul

Lead investors

Michał SołowowNational Center for Research & Development

Investors

Medical University of WarsawMichał SołowowNational Center for Research & DevelopmentNew Europe Ventures, LLC